2022. Evaluation of 1,5-Anhydroglucitol as a Biomarker for Type 2 Diabetes Mellitus in Patients without Overt Nephropathy. Brazilian Journal of Pharmaceutical Sciences. 57, (Nov. 2022). DOI:https://doi.org/10.1590/s2175-97902020000419078.